• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于影响日本眼压降低滴眼液依从性因素的全国性调查。

A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.

作者信息

Tsumura Toyoaki, Kashiwagi Kenji, Suzuki Yasuyuki, Yoshikawa Keiji, Suzumura Hirotaka, Maeda Toshine, Takeda Ryuji, Saito Hitomi, Araie Makoto

机构信息

Fussa Hospital, Tokyo, Japan.

Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, Japan.

出版信息

Int Ophthalmol. 2019 Feb;39(2):375-383. doi: 10.1007/s10792-018-0820-7. Epub 2018 Jan 12.

DOI:10.1007/s10792-018-0820-7
PMID:29330811
Abstract

INTRODUCTION

Few reports have investigated the status of adherence in Japan on a large scale. We aimed to investigate the status of adherence to topical glaucoma treatment and its associated factors.

METHODS

A nationwide survey was conducted as a prospective fashion. Participants in this survey were subjects with primary open-angle glaucoma, normal-tension glaucoma, or ocular hypertension or pseudoexfoliation glaucoma who had been prescribed anti-glaucoma ophthalmic eyedrops and whose ophthalmologist considered prescribing any fixed combination of ocular hypotensive eyedrops for the first time between 2011 and 2012. Subjects and their attending ophthalmologists independently completed a questionnaire by utilizing a fixed combination of ocular hypotensive eyedrops.

RESULTS

A total of 1358 ophthalmologists from 1071 medical institutions participated in this survey. We registered 4430 subjects (2049 males and 2381 females). In total, data from 3853 subjects (87.6%) were analyzed after inclusion of subjects based on inclusion and exclusion criteria. Good adherence was defined as not forgetting instillation during the past week. Rates of good adherence reported by subjects and ophthalmologists were 72.4 and 78.5%, respectively (P < 0.0001). The consistency of adherence evaluation between subjects and ophthalmologists was moderate [kappa score 0.5025 (95% confidence interval 0.4740-0.5309)]. Significant factors associated with adherence were size of clinic, age, gender, number of types of ocular hypotensive eyedrops, ease of instillation, preferred number of eyedrops, preferred frequency of instillation of eyedrops, and knowledge of glaucoma.

CONCLUSION

Adherence to ocular hypotensive eyedrops among Japanese subjects was relatively good. Concordance of adherence between subjects' reports and ophthalmologists' responses was moderate. Size of clinic, number of types of ocular hypotensive eyedrops, ease of instillation, preferred number of eyedrops, preferred frequency of instillation of eyedrops, and knowledge of glaucoma were associated with adherence among Japanese glaucoma subjects.

摘要

引言

很少有报告大规模调查日本的依从性状况。我们旨在调查局部青光眼治疗的依从性状况及其相关因素。

方法

以前瞻性方式进行了一项全国性调查。本次调查的参与者为原发性开角型青光眼、正常眼压性青光眼、高眼压症或假性剥脱性青光眼患者,他们曾被开具抗青光眼眼药水,且其眼科医生在2011年至2012年期间首次考虑开具任何固定组合的降眼压眼药水。受试者及其主治眼科医生通过使用固定组合的降眼压眼药水独立完成一份问卷。

结果

来自1071家医疗机构的1358名眼科医生参与了本次调查。我们登记了4430名受试者(2049名男性和2381名女性)。根据纳入和排除标准纳入受试者后,总共对3853名受试者(87.6%)的数据进行了分析。良好依从性定义为在过去一周内未忘记滴眼。受试者和眼科医生报告的良好依从率分别为72.4%和78.5%(P<0.0001)。受试者和眼科医生之间依从性评估的一致性为中等[kappa值0.5025(95%置信区间0.4740 - 0.5309)]。与依从性相关的显著因素包括诊所规模、年龄、性别、降眼压眼药水的类型数量、滴眼的难易程度、首选的滴眼次数、首选的滴眼频率以及青光眼知识。

结论

日本受试者对降眼压眼药水的依从性相对较好。受试者报告与眼科医生回答之间的依从性一致性为中等。诊所规模、降眼压眼药水的类型数量、滴眼的难易程度、首选的滴眼次数、首选的滴眼频率以及青光眼知识与日本青光眼受试者的依从性相关。

相似文献

1
A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.一项关于影响日本眼压降低滴眼液依从性因素的全国性调查。
Int Ophthalmol. 2019 Feb;39(2):375-383. doi: 10.1007/s10792-018-0820-7. Epub 2018 Jan 12.
2
Determinants of medication adherence to topical glaucoma therapy.影响局部青光眼治疗药物依从性的因素。
J Glaucoma. 2012 Apr-May;21(4):234-40. doi: 10.1097/IJG.0b013e31821dac86.
3
Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.将固定联合制剂转换为拉坦前列素 0.005%/马来酸噻吗洛尔 0.5% 固定联合制剂后 3 个月的降眼压效果和安全性。
J Ocul Pharmacol Ther. 2011 Dec;27(6):581-7. doi: 10.1089/jop.2011.0057. Epub 2011 Oct 19.
4
An objective evaluation of eyedrop instillation in patients with glaucoma.青光眼患者滴眼剂滴入的客观评估。
Arch Ophthalmol. 2009 Jun;127(6):732-6. doi: 10.1001/archophthalmol.2009.96.
5
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.电子监测的青光眼患者滴眼剂依从性差的危险因素。
Ophthalmology. 2009 Jun;116(6):1097-105. doi: 10.1016/j.ophtha.2009.01.021. Epub 2009 Apr 19.
6
Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).自我报告的滴眼液治疗不依从性的流行率及其相关因素:比利时眼科依从性研究 (BCSO)。
J Glaucoma. 2011 Sep;20(7):414-21. doi: 10.1097/IJG.0b013e3181f7b10e.
7
Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma.比较无防腐剂拉坦前列素滴眼液和 BAK 防腐剂拉坦前列素治疗眼高压或青光眼患者的疗效和安全性。
Br J Ophthalmol. 2013 Feb;97(2):196-200. doi: 10.1136/bjophthalmol-2012-302121. Epub 2012 Nov 30.
8
Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.电子监测以评估每日一次青光眼药物治疗的依从性及不依从的风险因素:自动给药提醒研究
JAMA Ophthalmol. 2014 Jul;132(7):838-44. doi: 10.1001/jamaophthalmol.2014.856.
9
Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.埃塞俄比亚梅内利克二世转诊医院青光眼患者对降眼压药物的依从性水平及其决定因素
BMC Ophthalmol. 2016 Aug 2;16:131. doi: 10.1186/s12886-016-0316-z.
10
Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.使用电子监测测量青光眼患者对溴莫尼定治疗的依从性。
J Glaucoma. 2011 Oct;20(8):502-8. doi: 10.1097/IJG.0b013e3181f3eb4a.

引用本文的文献

1
Topical Application of RNAi Therapy Using Surface-Modified Liposomes for Treating Retinal-Vein Occlusion.使用表面修饰脂质体的RNAi疗法局部应用于治疗视网膜静脉阻塞
Molecules. 2025 Jun 17;30(12):2622. doi: 10.3390/molecules30122622.
2
Factors Associated With High Adherence to Eye Drop Therapy for Dogs.与犬类滴眼剂治疗高依从性相关的因素。
Vet Ophthalmol. 2025 Jun 9;28(4):747-52. doi: 10.1111/vop.70039.
3
Intraocular Pressure Changes in Non-Surgical Eyes of Patients Admitted for Glaucoma Surgery.因青光眼手术入院患者未手术眼的眼压变化

本文引用的文献

1
Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence Among African Americans: "Glaucoma Management Optimism for African Americans Living with Glaucoma" (GOAL).一项基于文化的健康促进项目在提高非裔美国人青光眼药物依从性方面的可行性、患者可接受性及初步疗效:“非裔美国人青光眼管理乐观计划”(GOAL)
Curr Eye Res. 2016;41(1):50-8. doi: 10.3109/02713683.2014.1002045. Epub 2015 Jan 27.
2
Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.在实际临床实践中患者对局部降眼压治疗的依从性和持续性:0.01%比马前列素与0.004%曲伏前列素Z眼药水的比较
Clin Ophthalmol. 2014 May 14;8:927-35. doi: 10.2147/OPTH.S49467. eCollection 2014.
3
J Clin Med. 2024 Aug 1;13(15):4511. doi: 10.3390/jcm13154511.
4
Improvement of corneal epithelial damage after switching from the concomitant use of brinzolamide and brimonidine to a brinzolamide/brimonidine fixed-dose combination.从联合使用布林佐胺和溴莫尼定改为布林佐胺/溴莫尼定固定剂量复方滴眼剂后,角膜上皮损伤得到改善。
Jpn J Ophthalmol. 2024 Sep;68(5):556-561. doi: 10.1007/s10384-024-01088-w. Epub 2024 Jul 11.
5
Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits.兔眼应用后,表麻药在结膜的跨睑分布。
Jpn J Ophthalmol. 2024 Sep;68(5):594-602. doi: 10.1007/s10384-024-01070-6. Epub 2024 May 25.
6
Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions.卡替洛尔盐酸盐/拉坦前列素固定剂量组合滴眼液与其他β受体阻滞剂/前列腺素 FP 受体激动剂固定剂量组合滴眼液相比的持久性。
Jpn J Ophthalmol. 2023 Nov;67(6):658-667. doi: 10.1007/s10384-023-01020-8. Epub 2023 Aug 19.
7
Factors associated with achieving intraocular pressure lower than 15 mmHg by Trabectome surgery in primary open-angle glaucoma.与 Trabectome 手术治疗原发性开角型青光眼时眼压降至 15mmHg 以下相关的因素。
Sci Rep. 2021 Jul 12;11(1):14308. doi: 10.1038/s41598-021-93711-w.
8
Investigation of visual and physical factors associated with inadequate instillation of eyedrops among patients with glaucoma.调查与青光眼患者滴眼剂滴入不足相关的视觉和物理因素。
PLoS One. 2021 May 14;16(5):e0251699. doi: 10.1371/journal.pone.0251699. eCollection 2021.
9
Comparison of adherence between fixed and unfixed topical combination glaucoma therapies using Japanese healthcare/pharmacy claims database: a retrospective non-interventional cohort study.使用日本医疗保健/药房索赔数据库比较固定和非固定局部联合青光眼治疗的依从性:回顾性非干预性队列研究。
BMC Ophthalmol. 2021 Jan 21;21(1):52. doi: 10.1186/s12886-021-01813-w.
10
Miniaturization in Glaucoma Monitoring and Treatment: A Review of New Technologies That Require a Minimal Surgical Approach.青光眼监测与治疗的小型化:对需微创外科手术方法的新技术的综述
Ophthalmol Ther. 2019 Mar;8(1):19-30. doi: 10.1007/s40123-019-0161-2. Epub 2019 Feb 6.
Patient education preferences in ophthalmic care.眼科护理中的患者教育偏好。
Patient Prefer Adherence. 2014 Apr 25;8:565-74. doi: 10.2147/PPA.S61505. eCollection 2014.
4
Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study).提高青光眼药物治疗依从性:一项以患者为中心的干预措施的随机对照试验(诺维奇依从性青光眼研究)。
BMC Ophthalmol. 2014 Mar 24;14:32. doi: 10.1186/1471-2415-14-32.
5
Impact of patient access to Internet health records on glaucoma medication: randomized controlled trial.患者获取互联网健康记录对青光眼药物治疗的影响:随机对照试验
J Med Internet Res. 2014 Jan 15;16(1):e15. doi: 10.2196/jmir.2795.
6
Persistence with topical glaucoma therapy among newly diagnosed Japanese patients.新诊断日本患者中局部青光眼治疗的坚持情况。
Jpn J Ophthalmol. 2014 Jan;58(1):68-74. doi: 10.1007/s10384-013-0284-2. Epub 2013 Oct 25.
7
The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.新加坡青光眼患者的生活质量与药物依从性之间的关系。
J Glaucoma. 2015 Jun-Jul;24(5):e36-42. doi: 10.1097/IJG.0000000000000007.
8
Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.韩国患者青光眼药物治疗依从性不佳:一项多中心定性研究。
Jpn J Ophthalmol. 2013 Jan;57(1):47-56. doi: 10.1007/s10384-012-0188-6. Epub 2012 Oct 12.
9
Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial.个体化患者护理作为标准护理的辅助手段,以促进抗青光眼药物治疗的依从性:一项探索性随机对照试验。
Eye (Lond). 2012 Mar;26(3):407-17. doi: 10.1038/eye.2011.269. Epub 2011 Nov 18.
10
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review.青光眼和高眼压症患者治疗依从性和持续性的客观评估:一项系统评价
Patient Prefer Adherence. 2011;5:441-63. doi: 10.2147/PPA.S23780. Epub 2011 Sep 23.